Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001213900-24-028001
Filing Date
2024-03-29
Accepted
2024-03-29 16:31:05
Documents
4
Effectiveness Date
2024-03-29

Document Format Files

Seq Description Document Type Size
1 REGISTRATION STATEMENT ea0202562-s8_pasithea.htm S-8 50840
2 OPINION OF LOWENSTEIN SANDLER LLP ea020256201ex5-1_pasithea.htm EX-5.1 6880
3 CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM (MARCUM LLP) ea020256201ex23-2_pasithea.htm EX-23.2 2331
4 FILING FEE TABLE ea020256201ex-fee_pasithea.htm EX-FILING FEES 9778
  Complete submission text file 0001213900-24-028001.txt   70836
Mailing Address 2110 NARCISSUS CT VENICE CA 90291
Business Address 2110 NARCISSUS CT VENICE CA 90291 8184226172
Pasithea Therapeutics Corp. (Filer) CIK: 0001841330 (see all company filings)

EIN.: 851591963 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-278386 | Film No.: 24804459
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)